Projekte unter der Sponsorschaft der AIO-Studien-gGmbH


AIO-PAK-0113: Prospective Randomized Multicenter Phase II Trial to Investigate Intensified Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer (NEOLAP)


AIO-PAK-0313: Neoadjuvant plus adjuvant or only adjuvant nab-Paclitaxel plus Gemcitabine for resectable pancreatic cancer: - A prospective, randomized, controlled, phase II study of the AIO Pancreatic Cancer Group (NEONAX)


AIO-PAK-0114: Induction treatment with nab-paclitaxel/gemcitabine for first-line treatment of metastatic pancreatic cancer followed by either alternating application of gemcitabine monotherapy and nab-paclitaxel/gemcitabine or continuing application of nab-paclitaxel/gemcitabine: A randomized phase II study (ALPACA)